Hans Bishop

Hans Bishop is President, Founder, and Board Co-Chairman of Altos Labs. He has more than 30 years of experience in the biotechnology industry. Bishop served previously as the CEO of GRAIL, which was recently acquired by Illumina. From 2013 to 2018, he served as President and CEO at Juno Therapeutics, a company that he co-founded and that was acquired by Celgene. Prior to Juno, Bishop served as an Executive in Residence at Warburg Pincus. Earlier in his career, he was the Executive Vice President and Chief Operating Officer for Dendreon. Bishop also previously served as President of Specialty Medicine at Bayer Healthcare and Senior Vice President of Global Commercial Operations at Chiron Corporation. He currently serves as the Chairman of Sana Biotechnology and as a Director of Lyell Immunopharma and Agilent Technologies.